Gilead Analyst Sees Only 50% Chance That Coronavirus Drug Works

(Bloomberg) -- One of Gilead Sciences Inc.’s biggest bulls says the drugmaker’s experimental therapy for coronavirus has at best a 50/50 shot at success.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.